Future of Digital Trust Explored at Upcoming ISACA Conference Europe Featuring Opening Keynote Hannah Fry
Bringing together global industry experts and thought leaders, ISACA Conference Europe, 19-21 October 2022 in Rome and online, will examine the future of digital trust and look at emerging technologies, best practices, and leadership development topics. The hybrid, multi-day event will include a mix of in-person and virtual sessions that will also be available on demand, as well as interactive panel discussions on digital trust and new solutions to the industry’s current challenges.
The conference features more than 50 speakers, with opening keynote Hannah Fry, professor in the Mathematics of Cities at the Centre for Advanced Spatial Analysis at UCL and best-selling author. Other keynote speakers include award-winning author Carissa Véliz, an associate professor at the Institute for Ethics in AI and a fellow at Hertford College, University of Oxford, and Stefan Hyttfors, acclaimed futurist, author and global speaker on disruptive technologies, behavioural change and next-generation leadership.
ISACA Conference Europe offers sessions for professionals in infosec, cybersecurity, IT audit, privacy, governance and risk roles, each 25-75 long and providing the opportunity to earn up to 18 continuing professional education (CPE) credits. The tracks engage in peer-to-peer knowledge exchange across emerging themes such as the crypto ecosystem, third-party risk, privacy regulations, quantum computing, cybersecurity, digitalization, COBIT, and CMMI.
The beta launch of ISACA’s new Digital Trust Ecosystem Framework is unique to the program. Attendees will have early access when it becomes available.
“ISACA Conference Europe brings together digital trust professionals from across Europe with a common goal of sharing their knowledge, experience, challenges, ideas and solutions to explore how to bring their best ideas to life and pursue digital trust in their roles and at their organisations,” said ISACA Chief Global Strategy Officer Chris Dimitriadis. “This conference is our first opportunity to gather face-to-face in Europe since before the pandemic began and our first since we expanded our presence in Europe with an office in Dublin and a new staff team across the continent. We look forward to bringing our professional community together to help them advance in their careers and make an impact in their enterprises.”
ISACA will also host two optional pre-conference workshops for an additional fee, where attendees can earn up to 14 (CPE) credits—the two-day “How to Mature Your Privacy Compliance Program” or one-day “Cyber Supply Chain Risk Management: The Essentials” workshop.
For details and to register for ISACA Conference Europe 2022, visithttps://store.isaca.org/s/community-event?id=a334w000004h7yFAAQ. Companies interested in sponsorship opportunities can contact sponsorship@isaca.org.
About ISACA
ISACA is a global professional association and learning organization with more than 150,000 members who work in information security, governance, assurance, risk and privacy and a presence in 188 countries, including more than 220 chapters. In 2020, ISACA launched One In Tech, a philanthropic foundation.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220922005216/en/
Contact information
Esther Almendros, ealmendros@isaca.org, T: +1 847-660-5777, M: +34 692 669 722
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Edgio Named Winner of the Coveted Global InfoSec Awards During RSA Conference 20246.5.2024 19:00:00 EEST | Press release
Edgio is proud to announce it has received the Web Application Security award from Cyber Defense Magazine (CDM), the industry’s leading electronic information security magazine. According to Verizon’s Data Breach Investigation Report (DBIR), over 60% of data breaches were attributed to web applications, underscoring the urgent need for organizations to continuously manage threat exposure across their web applications and throughout the entire DevSecOps lifecycle. Committed to addressing the complex and evolving needs of organizations, Edgio continues to innovate and expand its services with its recent launch of Attack Surface Management (ASM) - a solution designed to discover all web assets, provide full inventory of technologies, detect security exposures and manage exposure response across an organization from a centralized management interface. ASM, coupled with Edgio’s holistic web security solutions and managed security services provide the industry’s first edge-enabled continuous
NetApp Appoints Market Growth and Revenue Operations Leader, Dallas Olson to Chief Commercial Officer Role6.5.2024 18:30:00 EEST | Press release
NetApp (NASDAQ: NTAP), the intelligent data infrastructure company, today announced Dallas Olson as the company’s new Chief Commercial Officer, reporting to NetApp’s President, César Cernuda. Olson brings over 25 years of experience building high-performance teams responsible for planning, operations, enablement, engagement, and go-to-market strategies. As NetApp’s CCO, Olson will oversee sales strategy driving business growth in key areas including AI and Keystone through specialist teams, enhance market presence, optimize sales models, foster strategic partnerships, champion a customer-centric approach, and drive initiatives to maintain NetApp’s position as a market leader primed for accelerated growth. “We’re thrilled for Dallas to join NetApp at a time of momentum for the company as we empower enterprises to make their data infrastructure intelligent with unified data storage built for innovation in the era of AI," said César Cernuda, President at NetApp. “Olson's previous achievem
Nanochon closes $4M Series Seed Prime6.5.2024 18:00:00 EEST | Press release
Nanochon, a Washington, DC-based orthopedic device biotech company has raised $4 million in its series seed prime fundraising round. The round was led by The University of Virginia Licensing and Ventures Group Seed Fund, with participation from Cultivate (MD), Alumni Venture Group, and Mountain State Capital, among others. Nanochon intends to use the funds to initiate its first in human clinical trials in the US in 2024, deepen research and development efforts, expand the company’s patent profile and grow its team. “We’re thrilled to close our funding round and begin our clinical program,” says Ben Holmes, CEO and co-founder. “Securing this funding is one step closer towards achieving Nanochon’s goals of eliminating the need for knee replacements, and greatly shifting the paradigm of arthritic joint care.” Nanochon will initiate a phase I trial in the US this year for its patented knee implant Chondrograft™. The device requires only minimally invasive surgery to regrow damaged cartilag
Biocytogen Enters Into Evaluation and Potential Licensing Agreement With BioCopy For TCR-mimic Antibodies6.5.2024 17:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotechnology company focused on the discovery of novel antibody-based therapeutics, today announced a TCR-mimic antibody evaluation and potential licensing agreement with BioCopy AG (“BioCopy”), a research-based biotechnology company headquartered in Basel, Switzerland. The agreement grants BioCopy access to fully human TCR-mimic antibodies targeting an intracellular antigen generated by Biocytogen’s proprietary RenTCR-mimicTM mice. BioCopy will conduct an evaluation and retain the option to license these antibodies for the development of novel cancer therapies. “We are glad to provide BioCopy with our TCR-mimic antibodies,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “Our in vivo matured TCR-mimic antibodies demonstrated favorable affinity and excellent specificity. Combined with BioCopy’s expertise in TCR-mimic antibody screening and engager development, we are optimistic that our collabo
NanoTemper Brings Spectral Shift Technology to the Protein Production Market With Andromeda X, Enabling Biopharma and CROs to Increase Efficiency of Expression Screening for Recombinant Protein Targets6.5.2024 16:17:00 EEST | Press release
NanoTemper Technologies, well known for creating biophysical tools that accelerate the work of drug discovery researchers, brings their groundbreaking Spectral Shift technology to the protein production market with the release of Andromeda X, an instrument that determines optimal expression alongside thermal stability of recombinant proteins in crude lysates. Andromeda X increases the efficiency of protein production teams at Biopharma and CROs, who now have the ability to optimize purification schemes for challenging, low-yield targets much faster, and with unprecedented insights on thermal stability during expression screening. “At NanoTemper, our vision of creating a world where every disease is treatable starts here, in early drug development. Without high-quality drug targets or protein therapeutics, researchers cannot realize this vision. So, we’ve adapted our reliable and trusted optics systems to provide valuable insights for those working to express and purify these critical t
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom